Clinical Trials Browser

Unknown × Nasopharyngeal Carcinoma × Injections × Clear all

NCT03707509 2022-07-01

Phase III Study of Camrelizumab in Combination With Chemotherapy in Recurrent/Metastatic Nasopharyngeal Carcinoma

Phase 3 Unknown

Nasopharyngeal Carcinoma

NCT04282070 2021-12-21

SHR-1701 in Patients With Recurrent/Metastatic Nasopharyngeal Carcinoma

Phase 1 Unknown

Nasopharyngeal Carcinoma

NCT04015661 2019-07-11

Induction Chemotherapy Followed by Concurrent Chemoradiotherapy in Patients With LA-NPC

Phase 2 Unknown

Nasopharyngeal Carcinoma